Drug Trial Radar · NCT07924267
A Single Ascending Dose and Multiple Ascending Dose Trial to Assess the Dose, the Efficacy and Oro-sensitivity of Two Modified Linoleic Acids NKS-3 and NKS-5
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Dec 10, 2025
Primary completion
Oct 10, 2026
Study completion Oct 26, 2026
Sponsor
- Lead sponsor
- EktaHIndustry
- Sponsor type
- Industry
- First posted
- Nov 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed as a single ascending dose and multiple ascending dose single-blind, placebo controlled, randomized, monocentric trial. 60 obese men and women will be recruited for single ascending dose (Groups 1,2,3), according to the following inclusion and non-inclusion criteria. 60 obese men and women will be recruited for multiple ascending doses (Groups 4,5,6), according to the following inclusion and non-inclusion criteria.
Conditions
- Obesity & Overweight
- Overweight (BMI > 30)
Interventions
NKS-3Drug
Investigational product is a modified linoleic acid, named NKS-3. This non-caloric agent, synthetized from linoleic acid, is a fat taste receptors agonist, targeting CD36 with also an impact on GPR120
NKS-5Drug
Investigational product is a modified linoleic acid, named NKS-5. This non-caloric agent, synthetized from linoleic acid, is a fat taste receptors agonist, targeting CD36 with also an impact on GPR120
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the release of satiety peptides (PYY, CCK, GLP-1) at different dosesTime frame: 8 to 10 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Service des Maladies de la Nutrition A, Institut National de nutrition de Tunis
Tunis, Tunisia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.